Joel Greenblatt's JNJ Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 213,036 shares of Johnson & Johnson (JNJ) worth $39.5 M, representing 0.17% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 776,210 shares. Largest reduction occurred in Q4 2015, reducing 793,610 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +32,599 | New Buy | 32,599 | $86.69 |
| Q4 2013 | -32,599 | Sold Out | 32,599 | $0.00 |
| Q1 2014 | +7,496 | New Buy | 7,496 | $98.19 |
| Q2 2014 | -7,496 | Sold Out | 7,496 | $0.00 |
| Q3 2014 | +14,319 | New Buy | 14,319 | $106.57 |
| Q4 2014 | +776,210 | Add 5420.84% | 790,529 | $104.57 |
| Q1 2015 | +42,667 | Add 5.40% | 833,196 | $100.60 |
| Q2 2015 | -833,196 | Sold Out | 833,196 | $0.00 |
| Q4 2015 | +39,586 | New Buy | 39,586 | $102.71 |
| Q1 2016 | +202,457 | Add 511.44% | 242,043 | $108.20 |
| Q2 2016 | -237,137 | Reduce 97.97% | 4,906 | $121.28 |
| Q3 2016 | +209,137 | Add 4262.88% | 214,043 | $118.13 |
| Q4 2016 | +261,679 | Add 122.26% | 475,722 | $115.21 |
| Q1 2017 | -184,426 | Reduce 38.77% | 291,296 | $124.55 |
| Q2 2017 | -266,363 | Reduce 91.44% | 24,933 | $132.27 |
| Q3 2017 | +55,950 | Add 224.40% | 80,883 | $130.01 |
| Q4 2017 | +159,084 | Add 196.68% | 239,967 | $139.72 |
| Q1 2018 | +150,859 | Add 62.87% | 390,826 | $128.15 |
| Q2 2018 | +23,338 | Add 5.97% | 414,164 | $121.34 |
| Q3 2018 | -49,031 | Reduce 11.84% | 365,133 | $138.17 |
| Q4 2018 | -36,757 | Reduce 10.07% | 328,376 | $129.05 |
| Q1 2019 | -106,786 | Reduce 32.52% | 221,590 | $139.79 |
| Q2 2019 | +113,272 | Add 51.12% | 334,862 | $139.28 |
| Q3 2019 | +16,288 | Add 4.86% | 351,150 | $129.38 |
| Q4 2019 | -180,415 | Reduce 51.38% | 170,735 | $145.87 |
| Q1 2020 | -25,188 | Reduce 14.75% | 145,547 | $131.13 |
| Q2 2020 | +54,091 | Add 37.16% | 199,638 | $140.63 |
| Q3 2020 | -40,758 | Reduce 20.42% | 158,880 | $148.88 |
| Q4 2020 | -37,720 | Reduce 23.74% | 121,160 | $157.38 |
| Q1 2021 | -64,562 | Reduce 53.29% | 56,598 | $164.35 |
| Q2 2021 | +10,557 | Add 18.65% | 67,155 | $164.74 |
| Q3 2021 | +45,479 | Add 67.72% | 112,634 | $161.50 |
| Q4 2021 | -10,078 | Reduce 8.95% | 102,556 | $171.07 |
| Q1 2022 | -24,489 | Reduce 23.88% | 78,067 | $177.23 |
| Q2 2022 | -1,388 | Reduce 1.78% | 76,679 | $177.51 |
| Q3 2022 | +19,696 | Add 25.69% | 96,375 | $163.36 |
| Q4 2022 | -5,174 | Reduce 5.37% | 91,201 | $176.65 |
| Q1 2023 | +25,141 | Add 27.57% | 116,342 | $155.00 |
| Q2 2023 | -1,670 | Reduce 1.44% | 114,672 | $165.52 |
| Q3 2023 | +10,320 | Add 9.00% | 124,992 | $155.75 |
| Q4 2023 | +35,351 | Add 28.28% | 160,343 | $156.74 |
| Q1 2024 | +11,956 | Add 7.46% | 172,299 | $158.19 |
| Q2 2024 | +45,724 | Add 26.54% | 218,023 | $146.16 |
| Q3 2024 | -386 | Reduce 0.18% | 217,637 | $162.06 |
| Q4 2024 | -18,510 | Reduce 8.50% | 199,127 | $144.62 |
| Q1 2025 | -100,695 | Reduce 50.57% | 98,432 | $165.84 |
| Q2 2025 | +85,914 | Add 87.28% | 184,346 | $152.75 |
| Q3 2025 | +28,690 | Add 15.56% | 213,036 | $185.42 |
Joel Greenblatt's Johnson & Johnson Investment FAQs
Joel Greenblatt first purchased Johnson & Johnson (JNJ) in Q3 2013, acquiring 32,599 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Johnson & Johnson (JNJ) for 49 quarters since Q3 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Johnson & Johnson (JNJ) was in Q4 2014, adding 790,529 shares worth $82.67 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 213,036 shares of Johnson & Johnson (JNJ), valued at approximately $39.5 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.17% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Johnson & Johnson (JNJ) was 833,196 shares, as reported at the end of Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.